Article abstract
Nature Cell Biology 9, 493 - 505 (2007)
Published online: 22 April 2007 | doi:10.1038/ncb1567
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Christopher J. Sarkisian1, Blaine A. Keister1, Douglas B. Stairs1, Robert B. Boxer1, Susan E. Moody1 & Lewis A. Chodosh1
Abstract
Activating Ras mutations can induce either proliferation or senescence depending on the cellular context. To determine whether Ras activation has context-dependent effects in the mammary gland, we generated doxycycline-inducible transgenic mice that permit Ras activation to be titrated. Low levels of Ras activation — similar to those found in non-transformed mouse tissues expressing endogenous oncogenic Kras2 — stimulate cellular proliferation and mammary epithelial hyperplasias. In contrast, high levels of Ras activation — similar to those found in tumours bearing endogenous Kras2 mutations — induce cellular senescence that is Ink4a–Arf- dependent and irreversible following Ras downregulation. Chronic low-level Ras induction results in tumour formation, but only after the spontaneous upregulation of activated Ras and evasion of senescence checkpoints. Thus, high-level, but not low-level, Ras activation activates tumour suppressor pathways and triggers an irreversible senescent growth arrest in vivo. We suggest a three-stage model for Ras-induced tumorigenesis consisting of an initial activating Ras mutation, overexpression of the activated Ras allele and, finally, evasion of p53–Ink4a–Arf-dependent senescence checkpoints.
- Departments of Cancer Biology, Cell and Developmental Biology, and Medicine, and The Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6160, USA.
Correspondence to: Lewis A. Chodosh1 e-mail: chodosh@mail.med.upenn.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Barriers to Ras transformationNature Cell Biology News and Views (01 May 2007)
Research highlightsNature Medicine News and Views (01 Jun 2007)
See all 3 matches for News And ViewsRESEARCH
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutationsNature Medicine Article (01 Feb 2001)
Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formationOncogene Original Article
See all 25 matches for Research
